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Background: Surgical aortic valve replacement (AVR) remains the standard of care for the treatment of operable, symptomatic aortic valve 
disease; however, to date, there are limited national data on the contemporary long-term outcomes following AVR in older individuals.
Methods: We examined long-term survival among 145,911 AVR patients ≥65 years of age undergoing AVR at 1,026 centers with participation 
in the Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Database from 1991-2007. In-hospital complications and long-term survival were 
stratified by age, STS perioperative risk of mortality (PROM), and several comorbidities. 
Results: The median patient age was 76 years, with 16% having chronic lung disease, 6% preoperative renal failure, 38% heart failure, and 12% 
prior cardiac surgery. The median survival in patients aged 65-69, 70-79, and ≥80 years undergoing isolated AVR was 13, 9, and 6 years, respectively. 
For AVR plus coronary artery bypass graft (CABG) procedures, median survival was 10, 8, and 6 years, respectively. While only 5% of isolated AVR 
patients had a high STS PROM (≥10%), their median survival was 2.5 to 2.7 years. Severe lung disease and renal failure were each associated with 
a 50% or greater reduction in median survival among all age groups when compared with those who did not have these comorbidities, while LV 
dysfunction and prior cardiac operation were associated with a 25% reduction in median survival.
Conclusions: Long-term survival following open AVR in the elderly is excellent, although patients with a high STS PROM and those with certain 
comorbidities carry a particularly poor long-term prognosis.
